Windtree Therapeutics (WINT) Misses Q1 EPS by 12c
Tweet
Share
E-mailGet Alerts WINT Hot Sheet
Join SI Premium – FREE
Windtree Therapeutics (NASDAQ: WINT) reported Q1 EPS of ($1.70), $0.12 worse than the analyst estimate of ($1.58). Revenue for the quarter came in at $75 thousand, versus $191 thousand reported last year.
For earnings history and earnings-related data on Windtree Therapeutics (WINT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shoe Station Group Inc. (SHOE) Tops Q2 EPS by 11c ; Offers Guidance
- Piper Sandler Starts AMD (AMD) at Overweight
- Piper Sandler Starts Qualcomm (QCOM) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
